» Authors » Y Shirota

Y Shirota

Explore the profile of Y Shirota including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 636
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Suda T, Shirota Y, Hodo Y, Wakabayashi T
J Gastroenterol Hepatol . 2019 Dec; 35(4):528. PMID: 31822035
No abstract available.
2.
Rossini P, Di Iorio R, Bentivoglio M, Bertini G, Ferreri F, Gerloff C, et al.
Clin Neurophysiol . 2019 Aug; 130(10):1833-1858. PMID: 31401492
The goal of this paper is to examine existing methods to study the "Human Brain Connectome" with a specific focus on the neurophysiological ones. In recent years, a new approach...
3.
Nakano M, Kubo K, Shirota Y, Iwasaki Y, Takahashi Y, Igari T, et al.
Lupus . 2019 Jul; 28(9):1062-1073. PMID: 31296139
Objective: The objective of this study was to investigate possible differences in treatment responses between two categories for the onset of lupus nephritis. Methods: We performed a multicentre, retrospective cohort...
4.
Halawa I, Shirota Y, Neef A, Sommer M, Paulus W
Brain Stimul . 2019 May; 12(5):1244-1252. PMID: 31085123
Introduction: Motor evoked potentials (MEP) in response to anteroposterior transcranial (AP) magnetic stimulation (TMS) are sensitive to the TMS pulse shape. We are now able to isolate distinct pulse properties,...
5.
Shirai T, Shirota Y, Fujii H, Ishii T, Harigae H
Scand J Rheumatol . 2019 Jan; 48(4):308-314. PMID: 30672367
: Within the spectrum of polyarteritis nodosa (PAN), cutaneous PAN (cPAN) is further classified into mild cPAN and severe cPAN which presents with ulcers, necrosis, or neuritis. As distinguishing between...
6.
Hanajima R, Terao Y, Shirota Y, Ohminami S, Nakatani-Enomoto S, Okabe S, et al.
Exp Brain Res . 2011 Aug; 214(2):317-21. PMID: 21842190
Reduced short-interval intracortical inhibition (SICI) is reported in Parkinson's disease (PD) and is considered to reflect abnormal GABAergic inhibitory system of the primary motor cortex in PD. We have recently...
7.
Hanajima R, Terao Y, Nakatani-Enomoto S, Okabe S, Shirota Y, Oominami S, et al.
Mov Disord . 2011 Feb; 26(4):685-90. PMID: 21328618
Background: Abnormally enhanced cortical rhythmic activities have been reported in patients with cortical myoclonus. We recently reported a new triad-conditioning transcranial magnetic stimulation (TMS) method to detect the intrinsic rhythms...
8.
Roescher N, Kingman A, Shirota Y, Chiorini J, Illei G
Ann Rheum Dis . 2010 May; 70(1):235-6. PMID: 20498204
Objectives: The detection of autoantibodies to the muscarinic receptor type 3 (M3R) in the serum of patients with Sjögrens syndrome (SS) by ELISA is controversial. A study was undertaken to...
9.
Shirota Y, Illei G, Nikolov N
Oral Dis . 2008 Feb; 14(3):206-16. PMID: 18282173
Many rheumatologic disorders, most notably Sjögren's syndrome, are associated with dental complications and in some cases oral diseases may trigger or drive connective tissue disease. During the past three decades...
10.
Iida H, Honda M, Kawai H, Yamashita T, Shirota Y, Wang B, et al.
Gut . 2005 May; 54(6):843-51. PMID: 15888795
Background And Aims: alpha-Fetoprotein (AFP), a tumour marker for hepatocellular carcinoma (HCC), is associated with poor prognosis. Using cDNA microarray analysis, we previously found that ephrin-A1, an angiogenic factor, is...